These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 19062528)

  • 21. Rare genetic causes of autosomal dominant or recessive hypercholesterolaemia.
    Soutar AK
    IUBMB Life; 2010 Feb; 62(2):125-31. PubMed ID: 20073037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [PCSK9: Structure and function. PCSK9 and low-density lipoprotein receptor. Mutations and their effects].
    Pedro-Botet J; Badimón L
    Clin Investig Arterioscler; 2016 May; 28 Suppl 2():3-8. PubMed ID: 27888903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies for proprotein convertase subtilisin kexin 9 modulation: a perspective on recent patents.
    Abifadel M; Pakradouni J; Collin M; Samson-Bouma ME; Varret M; Rabès JP; Boileau C
    Expert Opin Ther Pat; 2010 Nov; 20(11):1547-71. PubMed ID: 20849207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9.
    Rashid S; Curtis DE; Garuti R; Anderson NN; Bashmakov Y; Ho YK; Hammer RE; Moon YA; Horton JD
    Proc Natl Acad Sci U S A; 2005 Apr; 102(15):5374-9. PubMed ID: 15805190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia.
    Cunningham D; Danley DE; Geoghegan KF; Griffor MC; Hawkins JL; Subashi TA; Varghese AH; Ammirati MJ; Culp JS; Hoth LR; Mansour MN; McGrath KM; Seddon AP; Shenolikar S; Stutzman-Engwall KJ; Warren LC; Xia D; Qiu X
    Nat Struct Mol Biol; 2007 May; 14(5):413-9. PubMed ID: 17435765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment.
    Maxwell KN; Fisher EA; Breslow JL
    Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2069-74. PubMed ID: 15677715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PCSK9: a promising therapeutic target for dyslipidemias?
    Lambert G; Krempf M; Costet P
    Trends Endocrinol Metab; 2006 Apr; 17(3):79-81. PubMed ID: 16487721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of novel mutations in the catalytic domain of the PCSK9 gene.
    Cameron J; Holla OL; Laerdahl JK; Kulseth MA; Ranheim T; Rognes T; Berge KE; Leren TP
    J Intern Med; 2008 Apr; 263(4):420-31. PubMed ID: 18266662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial hypercholesterolemia and atherosclerosis in cloned minipigs created by DNA transposition of a human PCSK9 gain-of-function mutant.
    Al-Mashhadi RH; Sørensen CB; Kragh PM; Christoffersen C; Mortensen MB; Tolbod LP; Thim T; Du Y; Li J; Liu Y; Moldt B; Schmidt M; Vajta G; Larsen T; Purup S; Bolund L; Nielsen LB; Callesen H; Falk E; Mikkelsen JG; Bentzon JF
    Sci Transl Med; 2013 Jan; 5(166):166ra1. PubMed ID: 23283366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent patents on PCSK9: a new target for treating hypercholesterolemia.
    Li H; Li H; Ziegler N; Cui R; Liu J
    Recent Pat DNA Gene Seq; 2009; 3(3):201-12. PubMed ID: 19601924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The molecular basis of familial hypercholesterolemia in Lebanon: spectrum of LDLR mutations and role of PCSK9 as a modifier gene.
    Abifadel M; Rabès JP; Jambart S; Halaby G; Gannagé-Yared MH; Sarkis A; Beaino G; Varret M; Salem N; Corbani S; Aydénian H; Junien C; Munnich A; Boileau C
    Hum Mutat; 2009 Jul; 30(7):E682-91. PubMed ID: 19319977
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration.
    Zaid A; Roubtsova A; Essalmani R; Marcinkiewicz J; Chamberland A; Hamelin J; Tremblay M; Jacques H; Jin W; Davignon J; Seidah NG; Prat A
    Hepatology; 2008 Aug; 48(2):646-54. PubMed ID: 18666258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A common PCSK9 haplotype, encompassing the E670G coding single nucleotide polymorphism, is a novel genetic marker for plasma low-density lipoprotein cholesterol levels and severity of coronary atherosclerosis.
    Chen SN; Ballantyne CM; Gotto AM; Tan Y; Willerson JT; Marian AJ
    J Am Coll Cardiol; 2005 May; 45(10):1611-9. PubMed ID: 15893176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel mutation in proprotein convertase subtilisin/kexin type 9 gene leads to familial hypercholesterolemia in a Chinese family.
    Lin J; Wang LY; Liu S; Wang XM; Yong Q; Yang Y; DU LP; Pan XD; Wang X; Jiang ZS
    Chin Med J (Engl); 2010 May; 123(9):1133-8. PubMed ID: 20529551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A PCSK9 variant and familial combined hyperlipidaemia.
    Abifadel M; Bernier L; Dubuc G; Nuel G; Rabès JP; Bonneau J; Marques A; Marduel M; Devillers M; Munnich A; Erlich D; Varret M; Roy M; Davignon J; Boileau C
    J Med Genet; 2008 Dec; 45(12):780-6. PubMed ID: 18708425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protease variants, LDL, and coronary heart disease.
    Tall AR
    N Engl J Med; 2006 Mar; 354(12):1310-2. PubMed ID: 16554535
    [No Abstract]   [Full Text] [Related]  

  • 37. Severe hypercholesterolemia in four British families with the D374Y mutation in the PCSK9 gene: long-term follow-up and treatment response.
    Naoumova RP; Tosi I; Patel D; Neuwirth C; Horswell SD; Marais AD; van Heyningen C; Soutar AK
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2654-60. PubMed ID: 16224054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antagonism of secreted PCSK9 increases low density lipoprotein receptor expression in HepG2 cells.
    McNutt MC; Kwon HJ; Chen C; Chen JR; Horton JD; Lagace TA
    J Biol Chem; 2009 Apr; 284(16):10561-70. PubMed ID: 19224862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phaleria macrocarpa (Scheff.) Boerl fruit aqueous extract enhances LDL receptor and PCSK9 expression in vivo and in vitro.
    Chong SC; Dollah MA; Chong PP; Maha A
    J Ethnopharmacol; 2011 Sep; 137(1):817-27. PubMed ID: 21763412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond LDL cholesterol, a new role for PCSK9.
    Akram ON; Bernier A; Petrides F; Wong G; Lambert G
    Arterioscler Thromb Vasc Biol; 2010 Jul; 30(7):1279-81. PubMed ID: 20554949
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.